Study: CBD-Rich Cannabis Mitigates Symptoms In Children With Autism Spectrum Disorder

autism

ISRAEL: The daily administration of CBD-dominant cannabis extracts is associated with improved outcomes in adolescents with autism spectrum disorder (ASD) and severe behavioral problems, according to clinical data published in the Journal of Autism and Developmental Disorders. Israeli researchers assessed the efficacy of whole-plant cannabis extracts in a cohort of children with ASD. Participants were administered extracts containing a Read the full article…

Study: Patients With Tourette Syndrome Report Benefits From Cannabis

tourettes-syndrome

ISRAEL: Patients suffering from Tourette syndrome (TS) report symptomatic benefits following the use of medical cannabis, according to data published in the journal Parkinsonism and Related Disorders. Israeli researchers surveyed 42 patients with TS who had approval from the Health Ministry to use medical marijuana. Subjects typically reported reduced tic severity, better sleep, and improved mood following cannabis administration. Read the full article…

Thousands Of Peer-Reviewed Studies Specific To Medical Cannabis Have Been Published Over Past Decade

Medical-Science

ISRAEL: The total number of peer-reviewed scientific papers dedicated to cannabis, and the therapeutic use of cannabis in particular, has increased exponentially in recent years, according to data published the journal Population Health Management. Israeli researchers assessed trends in the number of scientific publications specific to cannabis as compared to all scientific publications during the years 2000 to 2017. They reported: Read the full article…

Cannabics Pharmaceuticals Announces Positive Results for Pilot Study on Treatment of Cancer Anorexia-Cachexia Syndrome (CACS)

MMJ reduces opioid use

Preliminary findings showed +80% of patients had increase in appetite and 60% +10% weight increase ISRAEL & MARYLAND: Cannabics Pharmaceuticals, a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced the results of its pilot study to test the efficacy of Cannabics capsules for the treatment of cancer anorexia-cachexia syndrome (CACS) in advanced Read the full article…

Yom Chai Forms Strategic Partnership With Israeli Research and Development Company Kaneh-B

research

Partnership Will Conduct Scientific Clinical Trials On ADHD; Distribute Approved European Dermal Products ISRAEL:  Yom Chai has entered into a strategic partnership with Kaneh-B to co-found the development and clinical validation of a range of cannabis based ADHD products. Yom Chai’s objective is to conduct scientific trials in Israel utilizing various Cannabinoid and Terpene profiles with the goal of Read the full article…

Father of THC Dr. Raphael Mechoulam Keynotes CannX Oct 14-16 In Tel Aviv

Dr Raphael Machoulam

ISRAEL: Dr. Raphael Mechoulam, Professor of Medicinal Chemistry at The Hebrew University of Jerusalem, Israel, and the man credited with first discovering and isolating THC will keynote the 3rd International Medical Cannabis Conference (CannX), October 14-16th in Tel Aviv. Speaking on The Plant Cannabinoids And The Endocannabinoid System — An Overview Of Research Over Five Decades, Dr. Mechoulam will set Read the full article…

Fibromyalgia Patients Report Subjective Benefits From Cannabis

Pain relief was reported by 94 percent of cannabis consumers

ISRAEL: Patients suffering from fibromyalgia frequently use cannabis to treat chronic pain and other symptoms of the disease, according to data published in the journal Pain Research and Treatment. Israeli researchers surveyed over 2,700 fibromyalgia patients. Of those who responded to the questionnaire, 84 percent reported consuming cannabis. “Pain relief was reported by 94 percent of cannabis consumers, while 93 percent Read the full article…

Yom Chai Signs MOU With Way Of Life Medical Cannabis For Israel, Portugal And Malta.

Yom Chai signs MoU with Way of Life Medical Cannabis

ISRAEL: New medical cannabis company Yom Chai has entered into a Memorandum of Understanding (“MOU”) with Way of Life Medical Cannabis to breed proprietary genetics, formulate, manufacture and distribute a wide range of Cannabis-based products to treat various medical conditions. Yom Chai’s objective is to conduct scientific trials in Israel utilizing various Cannabinoid and Terpene Read the full article…

iCAN Signs MoU With Yom Chai for Crohn’s Disease And Autism

the wide world of weed

ISRAEL: The Directors of Ananda Developments have announced that investee company iCAN has signed an MoU with a new Israeli Medical Cannabis company Yom Chai to develop and clinically validate cannabis based treatments for Crohn’s Disease, Autism and other neurodevelopmental, neurodegenerative and gastrointestinal diseases. Yom Chai has deep experience in the international medical cannabis market Read the full article…

Israeli Cannabis Producer Tefen Concludes $23 Million Local Sales Deal

Yom Chai signs MoU with Way of Life Medical Cannabis

Countries Around the World Seek to Import Israeli Cannabis Products but Cannot Due to Israel Government Bureaucracy Preventing Approval: “The Israeli Export Window is Closing.” ISRAEL: Tefen, a new Israeli licensed medical-grade cannabis producer has recently concluded two deals valued at approximately $23 million to supply 14 tons of medical-grade cannabis to a large Israeli processor and distributor Read the full article…